HiCisco: Shareholder return plan for the next three years (2025-2027)

Feb 28 00:00

HiCisco: Announcement on the progress of establishing a subsidiary in the US

Feb 10 00:00

HiCisco: Announcement on the establishment of a subsidiary in the US

Feb 6 00:00

HiCisco: Announcement on obtaining an IND application acceptance letter for the innovative drug HSK41959 tablets

Jan 17 00:00

HiCisco: Legal Opinion of Beijing Zhonglun (Shenzhen) Law Firm on the 2025 First Extraordinary General Meeting of Shareholders of Hisilicon Pharmaceutical Group Co., Ltd.

Jan 16 00:00

HiCisco: Announcement of Resolutions of the 2025 First Extraordinary General Meeting of Shareholders

Jan 16 00:00

HiCisco: Announcement on the overall conclusion of fund-raising investment projects and follow-up arrangements for fund savings

Jan 6 00:00

HiCisco: Announcement on Additional Provisional Proposals and Supplementary Notices for the 2025 First Extraordinary General Meeting of Shareholders

Jan 6 00:00

HiCisco: Announcement on capital increase and related transactions for holding companies

Jan 6 00:00

HiCisco: Announcement on the “Notice of Acceptance” of the IND Application for Two New Indications Obtaining the Innovative Drug HSK44459 Tablets

Dec 31, 2024 00:00

HiCisco: Announcement on the Notice of Convening the First Extraordinary General Meeting of Shareholders in 2025

Dec 31, 2024 00:00

HiCisco: Announcement on obtaining industry support funds

Dec 19, 2024 00:00

HiCisco: Announcement on obtaining industry support funds

Dec 2, 2024 00:00

HiCisco: Announcement on the inclusion of cligabarin benzenesulfonate capsules and coglitin tablets in the national medical insurance catalogue

Nov 29, 2024 00:00

HiCisco: Announcement on Obtaining the “Notice of Acceptance” of the IND Application for the Innovative Drug HSK44459 Tablets

Nov 19, 2024 00:00

HiCisco: Announcement on Obtaining an IND Application Acceptance Notice for the Innovative Drug HSK39004 Inhalation Powder

Nov 7, 2024 00:00

HiCisco: Announcement on the progress of establishing wholly-owned subsidiaries in the British Virgin Islands and Cayman

Oct 12, 2024 00:00

HiCisco: Notice on Obtaining the “Notice of Acceptance” of the Application for Marketing of the Innovative Drug HSK21542 Injection for New Indications

Sep 24, 2024 00:00

HiCisco: Announcement on obtaining the “Notice of Acceptance” of the IND application for the innovative drug HSK46575 tablets

Sep 24, 2024 00:00

HiCisco: Announcement on the establishment of separate wholly-owned subsidiaries in the British Virgin Islands and Cayman

Sep 20, 2024 00:00